Akums Drugs and Pharmaceuticals Ltd Share Price

Overview

Akums Drugs and Pharmaceuticals Ltd share price is currently ₹761.69, up by ₹17.27 (2.32%) from its previous closing price of ₹744.42. The share price has gained 12.42% over the past month and gained 63.05% over the past year. The stock's 52-week low and high are ₹400.70 and ₹770.16, respectively. Akums Drugs and Pharmaceuticals Ltd has a market capitalisation of ₹ 11,480.00 Cr. The share price was last updated on 24 Aug 2026, 03:59 PM IST.

Akums Drugs and Pharmaceuticals Ltd

AKUMS

₹0.00

₹17.27

2.32%

Healthcare

₹0.00(%)1D

Updated: 24 Aug 2026, 03:59:27 pm IST

Market Data

Open Price

₹759.74

Prev. Close

₹744.42

₹754.44

Day Low

₹764.38

Day High

₹400.70

52 Week Low

₹770.16

52 Week High

HealthcarePharmaceuticals & Drugs

CategoryMid Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

39.98

Sector PE

42.03

PB Ratio

3.52

Sector PB

5.82

EPS

19.05

Dividend Yield

0.64

Today's Volume

502.111 K

5 Day Avg. Volume

395.740 K

PEG Ratio

-1.63

Market Cap.

₹ 11,480.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Actions	Ex-Date	Record-Date
DividendsFinal Dividend of 50% at ₹1/Share	03-Jul-2026	03-Jul-2026
DividendsSpecial Dividend of 100% at ₹2/Share	03-Jul-2026	03-Jul-2026

Mutual Fund Ownership

Mutual Fund Holder	Jun 26 Shares held	Jul 26 Shares held
Franklin India Opportunities Fund - Growth	25.33 Lac	25.33 Lac no change
Franklin India Small Cap Fund - Growth	22.30 Lac	21.17 Lac (5.06%)
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth	21.80 Lac	19.53 Lac (10.42%)
Bandhan Small Cap Fund - Regular Plan - Growth	17.74 Lac	17.74 Lac no change
Nippon India Pharma Fund - Growth	14.89 Lac	14.05 Lac (5.64%)

Show all holdings

About Akums Drugs and Pharmaceuticals Ltd 👋

Akums Drugs and Pharmaceuticals Limited is an India-based pharmaceutical contract development and manufacturing company. The Company is engaged in the business of manufacturing, marketing, trading, importing, exporting, developing, testing and allied activities of pharmaceutical formulations of drugs, ayurvedic, nutraceuticals, food and dietary supplements, derma and cosmetics, healthcare and hospital products, over the counter (OTC) products, active pharmaceutical ingredients, excipients and compounds. Its segments include Contract Development and Manufacturing Operations (CDMO), International Branded Formulations, Domestic Branded Formulations, Active Pharmaceutical Ingredients (API) and Trade Generics. CDMO is engaged in formulation research and development, preparation and regulatory filing of dossiers, manufacturing formulations on contract basis, job work and testing services. API is engaged in the manufacture and sale of KSM, Intermediate and API products.